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The period of the first to second trimester transition in human pregnancy represents
a sensitive window for fetal organogenesis, particularly in regard to the development
of the male reproductive system. This is a time of relative analytical inaccessibility.
We have used a large national biobank of amniotic fluid samples collected at
routine amniocentesis to determine the impacts of exogenous endocrine disruptor
load on specific fetal biomarkers at this critical time. While adrenal and testicular
steroids are highly correlated, they are also mostly positively influenced by increasing
phthalate load, represented by the metabolites 7cx-MMeHP and 5cx-MEPP, by
perfluorooctane sulfonate (PFOS) exposure, and by smoking, suggesting an adrenal
stress response. In contrast, the testis specific biomarkers insulin-like peptide 3 (INSL3)
and androstenedione are negatively impacted by the phthalate endocrine disruptors.
Using a case–control design, we show that cryptorchidism and hypospadias are
both significantly associated with increased amniotic concentration of INSL3 during
gestational weeks 13–16, and some, though not all steroid biomarkers. Cases are
also linked to a specifically increased variance in the Leydig cell biomarker INSL3
compared to controls, an effect exacerbated by maternal smoking. No influence of
phthalate metabolites or PFOS was evident on the distribution of cases and controls.
Considering that several animal and human studies have shown a negative impact of
phthalate load on fetal and cord blood INSL3, respectively, the present results suggest
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that such endocrine disruptors may rather be altering the relative dynamics of testicular
development and consequent hormone production, leading to a desynchronization
of tissue organization during fetal development. Being born small for gestational age
appears not to impact on the testicular biomarker INSL3 in second trimester amniotic
fluid.
Keywords: INSL3, amniotic fluid, fetal steroids, cryptorchidism, hypospadias, phthalate, PFOS, testicular
dysgenesis syndrome
INTRODUCTION
Cryptorchidism and hypospadias represent two of the
commonest congenital malformations in newborn boys,
and both conditions have been linked to a hypothetical TDS
(Skakkebaek et al., 2001; Wohlfahrt-Veje et al., 2009) implying
a common etiology. This hypothesizes an insult of possible
environmental, lifestyle, or pharmacological nature during a
critical window of sensitivity in the transition from the first
to the second trimester, a time soon after sex determination
has occurred and the principal cellular components of the fetal
testes are being established. Research in rodents has highlighted
a role for Leydig cells and their major androgen products
in both conditions, an opinion reinforced by the symptoms
induced by some phthalate compounds administered at a
comparable gestational time (Foster, 2006; Howdeshell et al.,
2008; Wilson et al., 2008; Hu et al., 2009; Veeramachaneni and
Klinefelter, 2014; van den Driesche et al., 2017). Recent work
using human fetal testis explants and/or xenografts, however,
has suggested that the human fetus may be less susceptible
to phthalates than rodents (Albert and Jegou, 2014; Habert
et al., 2014), and a recent systematic review and meta-analysis
could show no epidemiological relationship between endocrine
disrupting chemicals and male reproductive disorders (Bonde
et al., 2017). Other studies point to a significant role of analgesic
compounds, such as paracetamol, taken during pregnancy, in
disrupting human fetal Leydig cell function (Kristensen et al.,
2012; Mazaud-Guittot et al., 2013; Ben Maamar et al., 2017). In
support of an effect of phthalates on the human male phenotype,
epidemiological studies have indicated a significant association
between maternal phthalate load and the androgen-dependent
anogenital distance (Swan et al., 2005; Bornehag et al., 2015).
Besides being major producers of the androgens
androstenedione and testosterone during this critical window
in human pregnancy (Ivell et al., 2017), fetal Leydig cells are
now known to make and secrete another major hormone, INSL3
(Ivell and Anand-Ivell, 2009). Genetic experiments in mice show
Abbreviations: 5cx-MEPP, mono(2-ethyl-5carboxypentyl) phthalate; 7cx-
MMeHP, mono(4-methyl-7-carboxyheptyl) phthalate; ACTH, adrenocorticotropic
hormone; DEHP, di(2-ethylhexyl) phthalate; DHEAS, dehydroepiandrosterone
sulfate; DHT, dihydrotestosterone; DiNP, diisononyl phthalate; DNPR,
Danish National Patient Registry; ED, endocrine disruptor; hCG, human
chorionic gonadotropin; HPG, hypothalamo-pituitary-gonadal; INSL3, insulin-
like peptide 3; IUGR, intrauterine growth restriction; LC/MS–MS, liquid
chromatography with tandem mass spectrometry; LH, luteinising hormone;
MoM, multiple of the median; PFOS, perfluorooctane sulfonate; RXFP2, relaxin
family peptide receptor 2; SGA, small for gestational age; TDS, testicular dysgenesis
syndrome; TRFIA, time resolved fluorescent immunoassay.
that ablation of the gene encoding either INSL3 or its unique
cognate receptor RXFP2 leads to bilateral cryptorchidism,
due to a failure of the gubernacular ligament to expand, and
thereby promote the first transabdominal phase of testicular
descent (Nef and Parada, 1999; Zimmermann et al., 1999; Kamat
et al., 2004). This role is supported by the treatment of mice
during mid-gestation with an INSL3 antagonist (Yuan et al.,
2010) leading to cryptorchidism. Furthermore, in mice treated
gestationally with the estrogen diethylstilbestrol, there is both
bilateral cryptorchidism and concomitant down-regulation
of Insl3 gene expression in the fetal testes (Emmen et al.,
2000), a finding paralleled by the increased incidence of
cryptorchidism amongst boys born of mothers similarly treated
with diethylstilbestrol during pregnancy (Palmer et al., 2009).
The common consensus is that whereas INSL3 is important for
the first phase of testicular descent, fetal androgens are more
important for the later inguino-scrotal phase of descent, as well
as for the proper formation of the external genitalia (Hutson
et al., 2013). However, it should be noted that androgens may be
required for the induction of the INSL3 receptor, RXFP2 (Yuan
et al., 2010), as well as for the relaxation and involution of the
cranial suspensory ligament, which retains the indeterminate
gonad in a peri-renal position (Lee and Hutson, 1999), implying
that androgens are also required during the first transabdominal
phase. Thus it appears that cryptorchidism and hypospadias
might have common roots in a disruption of Leydig cell function
and the production of INSL3 and androgens during early-mid
gestation.
Part of the difficulty in unraveling the etiology of
cryptorchidism is its highly heterogeneous manifestation
(Hutson et al., 2013). Testes may be arrested in a high abdominal
position or at any point before or within the inguinal canal.
Cryptorchidism may be bilateral or more commonly unilateral.
Moreover, it may also be transient, with a higher incidence of
cryptorchidism occurring in newborns compared with 3 month-
old infants; there is also a possibility for testes to re-ascend
from the scrotum during childhood. Anatomically, particularly
the first phase of testicular descent from a peri-renal position
to the inguinal ring is complicated by the fact that this occurs
with an opposing vector to other abdominal organs. This phase
of descent occurs because the thickening of the gubernaculum
under INSL3 influence effectively retains the fetal testes in the
inguinal region while the remaining organs and tissues, including
the kidneys, grow away in an antero-dorsal direction. Thus any
factor which would cause a temporal discordance of this fetal
growth trajectory could result in a ligament or a tissue being
interposed in the normal path of movement of one or other
Frontiers in Physiology | www.frontiersin.org 2 April 2018 | Volume 9 | Article 406
fphys-09-00406 April 21, 2018 Time: 11:38 # 3
Anand-Ivell et al. Amniotic Fluid INSL3 and Cryptorchidism
testes, leading also to cryptorchidism (mostly unilateral; Hutson
et al., 2013).
Regarding hypospadias, evidence points to this being largely
a complication involving fetal androgen-deficiency (Kalfa et al.,
2009), though it should be noted that androgens are also made
in substantial amounts by the fetal adrenals of both sexes as well
as by the testes (Wudy et al., 1999; Anand-Ivell et al., 2008; Scott
et al., 2009; Ivell et al., 2017). Moreover, it is still not clear whether
the human fetal testis is dependent upon an intact and functional
HPG axis (and/or fetal hCG), or whether other factors may be
involved in determining androgen production (Scott et al., 2009).
For example, we know that the mouse fetal testes are largely
independent of LH stimulation, rather being driven by ACTH
as for the fetal adrenal (O’Shaugnessy et al., 2003). Moreover,
one study suggests that human fetal Leydig cells at least up to
18 weeks are also independent of hCG (Word et al., 1989), though
a more recent study indicates a clear stimulation of testosterone
production by hCG (Hallmark et al., 2007).
One of the major difficulties in understanding the etiology
of these two common congenital ailments is the fact that the
critical period during human pregnancy which is implicated is
also one of the experimentally least accessible. We and others
have shown that amniotic fluid collected at routine genetic
amniocentesis serves as a useful matrix by which to explore
the endocrinology of the growing second trimester fetus (Wudy
et al., 1999; Anand-Ivell et al., 2008). Most such samples are
collected between gestational weeks 12 and 16, a time at which
amniotic fluid still represents very much an exudate of fetal
serum combined with other fluid components derived from the
amniotic membranes (Underwood et al., 2005; Beall et al., 2007).
Later in pregnancy, when the fetal skin has become keratinized,
this simple relationship to fetal serum is probably no longer valid
(Bacchi-Modena and Fieni, 2004). The present study represents
the largest ever (425 controls; 421 cryptorchid; 109 hypospadias)
case–control study to assess the role of fetal androgens and INSL3
in subsequent cryptorchidism and hypospadias, using second
trimester amniotic fluid samples collected in Denmark as part of
a national biobank (Jensen et al., 2012). Preliminary results from
this study have already been published (Jensen et al., 2012, 2015;
Toft et al., 2016); here we extend these analyses and specifically
address those factors influencing Leydig cell function and which
may be altered in subsequent cryptorchidism and hypospadias,
and focusing on the critical window of sensitivity (weeks 13–16).
MATERIALS AND METHODS
Study Population
Amniotic fluid samples were derived from a Danish biobank
maintained at the State Serum Institute (SSI) in Copenhagen.
Amniotic fluid samples, which had been collected at routine
amniocentesis between 1980 and 1996, were selected from 25,105
samples from live-born singleton male offspring pregnancies
which had complete obstetric data in the Danish Medical Birth
Registry. Samples were centrifuged, and supernatants stored at
−20◦C until analysis. Main indications for amniocentesis were
age (≥35 years) or increased risk of congenital malformation
based on maternal serum analysis. The date of amniocentesis,
date of birth, and estimated gestational age at birth were
used to calculate the gestational week of amniocentesis (Jensen
et al., 2012). Unique person identifiers were used to obtain
offspring gender, gestational age at birth, parity, birth weight,
and Apgar score (Knudsen and Olsen, 1998; Pedersen et al.,
2006). All selected cryptorchid cases (n = 421; 1.64%) had a
diagnosis of undescended testis according to the International
Classification of Disease, as well as a corrective surgical procedure
according to the Surgery and Treatment Classification of the
Danish National Board of Health or the Nordic Classification
of Surgical Procedures, as listed in the DNPR up to November
2008 (Lynge et al., 2011). To avoid possible inclusion of cases
of iatrogenic cryptorchidism, boys with an inguinal hernia repair
were excluded. The hypospadias group (N = 109; 0.43%) included
all boys with that diagnosis in the DNPR. An equivalent number
(n = 425) of controls were randomly selected from the 25,105
boys with complete medical entries in the DNPR. Full details of
inclusion criteria are given in Jensen et al. (2015).
This study was approved by the Danish Regional Ethics
Committee, the Danish National Board of Health, and the Danish
Data Protection Agency.
Analyses and Parameters
Insulin like peptide 3 was measured using a modified TRFIA
as recently described (Anand-Ivell et al., 2013; Jensen et al.,
2015). This assay used a sample volume of 0.1 ml and had
a limit of detection of 10 pg/ml and inter- and intra-plate
coefficients of variation of ≤8 and <1%, respectively. Because, it
had previously been shown that INSL3 in amniotic fluid indicated
a marked dependence on gestational age (Anand-Ivell et al.,
2008), values were also converted to MoM to account for this
additional variable factor (Lenke et al., 1989). Because of volume
restrictions INSL3 could only be measured in 243 controls,
227 cryptorchids (bilateral and unilateral combined), and 73
hypospadias cases. The steroids androstenedione, testosterone,
17OH-progesterone, progesterone, DHEAS, and cortisol were
all assayed using LC/MS–MS as previously described (Jensen
et al., 2015). Cotinine concentration, as an index for acute
maternal exposure to tobacco smoke, was measured as previously
(Jensen et al., 2015), with smokers defined as those women with
amniotic fluid levels >85 ng/ml, and passive smokers as those
with levels 85 > 25 ng/ml (Jauniaux et al., 1999). Non-smokers
had <25 ng/ml cotinine. Fetuses were defined as SGA or not
using the formula of Marsal et al. (1996). This calculation is based
on ultrasound observations of uncomplicated pregnancies from
four Scandinavian centers and calculates SGA as >2 standard
deviations below the mean corrected birth weight. The two
major phthalate metabolites 5cx-MEPP deriving from exposure
to DEHP and 7cx-MMeHP, deriving from DiNP, as also PFOS
were measured by LC/MS–MS as previously described in detail
(Jensen et al., 2012; Toft et al., 2016) with limits of detection at
0.05, 0.02, and 0.02 ng/ml, respectively. Sample numbers available
for measuring 5cx-MEPP, 7cx-MMEHP, and PFOS across all
gestational ages were 300, 270, and 75 for controls, cryptorchids,
and hypospadias cases, respectively, and for weeks 13–16, 190,
146, and 48; for measuring steroids across all gestational ages, N
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was 258, 237, and 79 for controls, cryptorchids, and hypospadias
cases, respectively, and for weeks 13–16, the corresponding
figures were 164, 123, and 51.
Many of the samples measured had been stored for up to
30 years at−20◦C prior to analysis. They might thus have suffered
evaporation/sublimation and/or analyte degradation in that time.
To check this, measured parameters were analyzed against both
date of sample collection and total volume of stored sample. No
significant trends for any analyte were identified (Jensen et al.,
2012). For INSL3 we have shown that serum samples stored at
−20◦C for at least 5 years remained stable with no significant
difference in INSL3 content (data not shown), and previously
we have shown that human amniotic fluid samples maintained
INSL3 content over several freeze-thaw cycles and when left at
room temperature for 24 h without significant change (Anand-
Ivell et al., 2008).
Statistical Analysis
Data were analyzed using GraphPad Prism version 7 or the SPSS
package (for multiple correlation analysis). For some analyses,
data were grouped according to week of amniocentesis, where
for example week 16 represented all samples from 16+0 to
16+6. Column statistics were assessed by Levene’s test (Levene,
1960), as described in SPSS, to check for equality of variance.
Where variance was shown to be unequal, comparisons used the
Mann–Whitney non-parametric test; otherwise significance was
estimated by ANOVA followed by Newman–Keuls or Student’s
t post hoc tests. Continuous variables were log-transformed
prior to statistical analysis. Multiple correlation analysis used
untransformed data and was corrected against gestational week
of amniotic fluid sample as confounder, since several parameters
showed significant trends across gestation (Supplementary
Figure S1).
RESULTS
Amniotic Fluid INSL3 and Gestational
Age at Amniocentesis
Figure 1 shows the distribution of INSL3 concentration in
amniotic fluid plotted against gestational age at amniocentesis
for controls (red squares), cryptorchid (green triangles), and
hypospadias (purple circles) cases. For cryptorchids, unilateral,
bilateral and undefined cases were combined, since these showed
no significant differences for any parameter measured. All data
appear to fit a common distribution with neither cases nor
controls appearing to depart from this pattern, which closely
follows what we had shown previously for a smaller collective
of United States subjects (Anand-Ivell et al., 2008). There is
a clear maximum between gestational weeks 13 and 16, with
most values declining rapidly after that time. Closer inspection,
however, reveals that for all cases compared to controls there
appears to be skewness in the data suggesting higher INSL3
values for cases in the earlier weeks of gestation (Figure 2A).
Since there are no significant differences in INSL3 values within
groups between weeks 13 and 16, for which these concentrations
represent maximum values, these results can be pooled to provide
FIGURE 1 | Scatter-plot of human amniotic fluid INSL3 concentration for all
available samples from normal controls (red squares), combined cryptorchid
cases (green triangles), and hypospadias cases (purple circles), plotted
against gestational week of amniocentesis.
the summary Figure 2B. This panel shows that in the early
second trimester, when amniotic fluid INSL3 is maximal, both
cryptorchid and hypospadias cases have significantly elevated
INSL3 concentration compared to controls. The mean INSL3
concentration for the control subjects is similar to what had
been shown previously for United States male pregnancies at this
gestational time (ca. 0.10 ng/ml; Anand-Ivell et al., 2008), as well
as for a smaller Danish set collected with a much shorter storage
time (ca. 0.12 ng/ml; Bay et al., 2008).
When INSL3 values for weeks 13–16 are corrected for
gestational age by converting to MoM, we still observe a
significant difference in the mean values for controls versus both
cryptorchids and hypospadias cases (Figure 2C). There is also
a significant difference in the variance between the cryptorchid
(unilateral + bilateral) and the control groups for this data-set,
as well as between the hypospadias and control groups, assessed
using Levene’s test.
We also compared the residual INSL3 concentrations in
weeks 17–21 for cases and controls (Figure 2D). Although the
uncorrected mean values are reduced in both cryptorchid and
hypospadias cases compared to controls, this does not reach
statistical significance, probably due to the large proportion of
samples at or close to the assay limit of detection. Converting to
MoM does not alter this (not shown).
Amniotic Fluid INSL3 and Maternal
Smoking
Comparing amniotic fluid samples for smokers, passive smokers,
and non-smokers (cotinine >85, 25–85, and <25 ng/ml,
respectively) for INSL3 MoM values for all gestational ages,
shows no differences, when all cases and controls are pooled
(data not shown). However, when separated out into cases
versus controls (Figure 3), INSL3 MoMs are significantly
greater (p < 0.003) in the cryptorchid group for non-smokers
versus controls, though just not significant for smokers (passive
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FIGURE 2 | Frequency distributions of amniotic fluid INSL3 concentration (means + SEM) collected at gestational weeks 13–16 for controls, combined cryptorchids
and hypospadias cases (A). Since individual weeks between 13 and 16 were not significantly different from one another for cases and controls, these were
combined in (B) (expressed as absolute concentration) and (C) (expressed age-corrected as MoM). (D) As in (B) but for gestational weeks 17–22. Differences
between means were significant only where indicated. 9 Represents significance for Levene’s test for differences in variance.
smokers are intermediate between smokers and non-smokers
and are omitted here for clarity). Both smokers and cases
(cryptorchid/hypospadias) indicate a higher overall variance
in INSL3 MoM, thus accounting for the failure to achieve
significance in the absolute differences. Correlation analysis
shows no relationship between individual amniotic cotinine
concentration and either INSL3 concentration or INSL3 MoM
values in cases or controls or in both combined, nor when data
are restricted to weeks 13–16 (Supplementary Tables S1–S5).
Amniotic Fluid INSL3 and Fetal Size for
Gestational Age
In order to determine whether amniotic fluid INSL3
concentration might be related to intrauterine growth, we
applied the formula of Marsal et al. (1996) in order to identify
those fetuses born SGA. There was a higher proportion of such
SGA pregnancies in both cryptorchid (9.3%) and hypospadias
(8.2%) groups, compared to the controls (4.9%). Pregnancies
identified as SGA were then compared with non-SGA normal
pregnancies in regard to amniotic INSL3 concentration,
comparing cases and controls pooled, as well as individually
(Figure 4). Other than the reported increased variance for
cryptorchids, there appeared to be no significant impact on
the INSL3 MoM of being born SGA. The same was also true
for absolute INSL3 concentrations restricted to weeks 13–16.
We also see no relationship between INSL3 expression and
gestational age at birth (data not shown).
Amniotic Fluid INSL3 and Steroid
Concentrations
For male pregnancies, steroids measured in amniotic fluid
derive from the fetal testis, the fetal adrenal gland, and in
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FIGURE 3 | Age-corrected INSL3 MoM values for all gestational weeks
combined for cases and controls, separated into active smokers
(cotinine > 85 ng/ml) and non-smokers (cotinine < 25 ng/ml). Passive
smokers (cotinine 25 < 85 ng/ml) were intermediate and omitted for clarity.
Significant differences between means were only evident amongst
non-smokers. 9 Represents significance for Levene’s test for differences in
variance. ns, not significant.
FIGURE 4 | Age-corrected INSL3 MoM values for all gestational weeks
combined for cases and controls, separately and together (total), separated
into pregnancies calculated to be SGA and normal pregnancies (not SGA).
Only the difference between non-SGA controls and cryptorchids was
considered significantly different.
small part from the placenta (Figure 5; Ivell et al., 2017).
Comparisons between amniotic fluid steroids from male
and female fetuses (Wudy et al., 1999; Anand-Ivell et al.,
2008) indicate that testosterone and androstenedione are
predominantly of testicular origin, being enriched for male
fetuses. In contrast, progesterone, 17OH-progesterone, DHEAS
and cortisol do not differ in relation to fetal gender (Wudy et al.,
1999), and are thus predominantly of adrenal and/or placental
origin. Not surprisingly, because of their common metabolic
pathways, all measured steroids are highly correlated to one
another (p < 0.001), when measured across gestation for cases
and controls combined (Supplementary Table S1). Absolute
concentrations of the various steroids measured in amniotic
fluid show that androstenedione (2–10 ng/ml; 5–95% confidence
limits) is 3–4 fold higher than testosterone (0.5–3.0 ng/ml), and
comparable in amount to 17OH-progesterone (4–10 ng/ml).
Cortisol and DHEAS are greater again (5–100 ng/ml) and
illustrate the larger steroidogenic capacity of the adrenal
gland at this time of gestation. Progesterone (also of
placental/luteal origin and a major steroid precursor in
all pathways) is highest at 100–300 ng/ml concentration.
Comparing steroid concentrations across gestational weeks,
there is no significant effect of gestational age (weeks 11–
21) on androstenedione, testosterone, or progesterone. For
cortisol, 17OH-progesterone and DHEAS there is a small but
significant trend for increasing concentration in amniotic fluid
between weeks 11 and 21 (Supplementary Figure S1), but
only for cortisol is this trend evident between the critical weeks
13–16.
Androstenedione, 17OH-progesterone, DHEAS and cortisol,
though not testosterone or progesterone, are positively correlated
(p < 0.02) with cotinine levels (Supplementary Table S1; all
cases and controls combined), implying that maternal smoking
is promoting increased steroidogenesis.
Comparing all cases and controls for all steroids measured and
over all gestational ages, showed small but significant differences
for testosterone (p < 0.05) and for progesterone (p < 0.05)
for hypospadias cases versus controls, where for both steroids
these were mildly elevated (Figure 6). Cryptorchid cases were
significantly elevated compared to controls for progesterone and
also for androstenedione (Figure 6). However, when only weeks
13–16 are considered, then probably because of the reduced
sample size only testosterone is significantly different (18%
increased; p < 0.05) between cases and controls, and then only
for hypospadias cases (Supplementary Figure S2).
It should be noted that because of lack of sufficient sample
availability, it was not possible to measure all parameters in
all samples. Thus only where both INSL3 and all measured
steroids were available for the same amniotic fluid samples
could multiple correlation analysis be carried out. As might
be anticipated for major Leydig cell products and comparing
samples from all gestational weeks, there is a statistically positive
correlation between INSL3 MoM and in order of significance,
testosterone (p < 0.001), androstenedione (p = 0.005), and
DHEAS (p = 0.043), for cases and controls combined, and
corrected for gestational week (Supplementary Table S1). For
controls only (Supplementary Table S2), there is a positive
correlation for androstenedione (p = 0.007) and testosterone
(p = 0.04). Amongst cryptorchids (Supplementary Table S3), a
significant positive correlation with INSL3 MoMs is observed
only for testosterone (p < 0.001), although INSL3 concentration
itself also correlates strongly with androstendione (p = 0.005). No
correlations were observed for INSL3 amongst the hypospadias
cases (Supplementary Table S4).
As explained earlier, INSL3 concentrations limited to
weeks 13–16 are more informative, representing maximal
and physiologically relevant INSL3 expression. When steroids
are now compared, we see a significant positive correlation
between INSL3 MoMs (as also INSL3 concentration) and
both androstenedione (p = 0.01) and testosterone (p < 0.01;
Supplementary Table S5).
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FIGURE 5 | Schematic to illustrate the principal steroidogenic pathways in the male human fetus for both testes and adrenals. In bold type (red or blue) are indicated
those steroids used here as biomarkers of fetal steroidogenesis.
FIGURE 6 | Mean steroid concentrations in amniotic fluid combined across all
gestational ages, separated into normal controls, combined cryptorchid and
hypospadias cases. ∗p < 0.05.
Influence of Xenobiotic Compounds
The present study has assessed the amniotic fluid concentration
of 5cx-MEPP as the chief metabolite of DEHP, and 7cx-
MMeHP as the main metabolite of DiNP, as well as the
fluorinated compound PFOS. Firstly, both 5cx-MEPP, and
7cx-MMeHP, showed small but significant trends to increase
across gestation (weeks 11–22; cases and controls combined;
Supplementary Figure S1). Only 7cx-MMeHP showed a
small but significant (p < 0.05) correlation (negative)
with cotinine levels (Supplementary Table S1; cases and
controls combined; Supplementary Table S2; controls only).
Importantly, both phthalate metabolites were positively
correlated amongst each other (p < 0.001; cases and controls
combined; Supplementary Table S1). 5cx-MEPP was also highly
positively correlated (p < 0.5 to p < 0.001; Supplementary
Table S1) with all steroids measured, except for progesterone
(not significant). In contrast, cx7-MMeHP was correlated
only with androstenedione (p < 0.02; negatively) and DHEAS
(p = 0.002; positively).
Comparing cases with controls across the gestational range,
there was no significant difference in mean or variance for
either of the measured phthalate metabolites (not shown). When
samples are restricted to the window of sensitivity for testis
development in weeks 13–16, there is also no significant
difference between cases and controls (Supplementary
Figure S2).
When we compare INSL3 values for weeks 13–16 as
representative of Leydig cell functionality at this critical time,
then there is a negative correlation (p = 0.04) with 7cx-
MMeHP for controls only (not shown), as well as cases and
controls combined (Supplementary Table S5), and a similar
negative correlation (p < 0.04) with 5cx-MEPP for cases and
controls combined (Supplementary Table S5). There is no
correlation between INSL3 and any phthalate metabolite within
the cryptorchid and hypospadias cases alone at this restricted
time window in gestation (not shown).
The environmental pollutant PFOS was significantly positively
correlated with all steroids measured (cases and controls
combined; all gestational weeks) as well as with the phthalate
metabolites 7cxMMEHP (Supplementary Table S1). PFOS was
not correlated with INSL3 MoM values across gestation (weeks
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11–21; Supplementary Table S1), nor when data were restricted
to gestational weeks 13–16 (Supplementary Table S5). As for the
phthalate metabolites, also PFOS exposure showed no statistically
significant differences between cases and controls within the
critical window of weeks 13–16 (Supplementary Figure S2).
None of the above significant relationships was altered when
multiple correlation analysis was additionally corrected for either
cotinine and/or PFOS concentration as possible confounders (not
shown).
DISCUSSION
Cryptorchidism and hypospadias are amongst the commonest
malformations in newborn infants representing, respectively,
2–9 and 0.2–0.7% (Main et al., 2010) of all male births,
and are considered by some to be symptoms of a common
TDS (Wohlfahrt-Veje et al., 2009). Such disturbances of sexual
development in male human offspring are thought to have their
origins relatively early during pregnancy, soon after SRY-driven
sex determination and during early testicular organogenesis. This
corresponds approximately to the end of the first trimester and
the early second trimester of pregnancy, though recent studies
using human fetal testis explants suggest weeks 8–10 as those
most sensitive in this regard to the analgesic ibuprofen (Ben
Maamar et al., 2017). Our understanding of the etiology of
these conditions derives largely from animal experimentation
as well as from sporadic genetic mutations in the human
population. Whilst there is an obvious role here for fetal testicular
androgens, we still know relatively little about how these and
other factors influence early stages of the relevant organogenesis.
Recently and largely based on animal experimentation, there
is concern that maternal exposure to certain endocrine
disrupting chemicals in the environment may be exacerbating
the incidence of such disorders (Diamanti-Kandarakis et al.,
2010; Juul et al., 2014), though a recent epidemiological meta-
analysis failed to identify such a relationship (Bonde et al.,
2017).
Unfortunately, the highlighted critical period of early
pregnancy is also a time in the human which is analytically
relatively inaccessible, with assessment of pollutants and/or end-
point physiology relying heavily on indirect measurement, e.g.,
maternal urine, breast milk, cord blood hormones, perinatal,
juvenile, or even adult phenotype. Amniocentesis is a procedure
whereby a sample of amniotic fluid and contained fetal cells is
removed by abdominal needle puncture. It is routinely offered
to older women, or where a genetic risk is suspected, during
weeks 12–20 of pregnancy for fetal genetic analysis. The resulting
amniotic fluid supernatants thus represent a unique opportunity
to explore human fetal metabolism at an otherwise relatively
inaccessible period of pregnancy. In the present study we have
taken advantage of the largest known biobank of preserved
amniotic fluid samples to assess known markers of fetal testis
physiology within the sensitive window of development and
compare these in a case–control format, together with known
sentinel ED substances, to determine how these might be related
at this critical period during human gestation.
Of the biomarkers assessed, only INSL3 is absolutely specific
for the steroid-producing Leydig cells of the fetal testis (Ivell
and Anand-Ivell, 2009). Because of this specificity of expression
at a time when many organ systems are actively developing,
INSL3 has been considered an important biomarker for more
general fetal organogenesis at this time (Anand-Ivell and
Ivell, 2014). Amongst the steroids, both androstenedione and
testosterone are relatively specific for the fetal testis, though
are also produced by the fetal adrenal gland which is very
active at this time in pregnancy. Of the other steroids measured,
these are largely products of the fetal adrenal gland (Ivell
et al., 2017). INSL3 is responsible for the first transabdominal
phase of testicular descent and is thus directly implicated in
cryptorchidism. Activated androgen receptors are involved both
in cryptorchidism (early and late stages) as well as in hypospadias
and associated malformations. In this context it is important to
note that whilst fetal testosterone is a very important androgen,
androstenedione also acts as a weak androgen (Chen et al.,
2004), and can additionally activate estrogen receptors alpha
and beta (Miller et al., 2013), which may also be involved in
gonadogenesis (Cederroth et al., 2007). However, testosterone
itself is less important than its metabolite DHT, which is produced
locally in target tissues. Recently, it has been shown also for the
human fetus, that significant amounts of DHT can be generated
in the fetal testis by the so-called ‘back-door’ pathway, which
avoids testosterone (Fukami et al., 2013; Figure 5). Thus whilst
the biomarkers selected in this study are likely to reflect well
aspects of testicular (in particular Leydig cell) physiology, they
may not be fully informative about factors responsible for the
etiology of cryptorchidism and hypospadias.
Reflecting its high cell-type and fetal specificity, amniotic
INSL3 concentration is most informative as a biomarker of
Leydig cell function. However, a factor of concern is the
high number of samples with low or undetectable INSL3
concentration. Similar observations were made previously
(Anand-Ivell et al., 2008). There is no evidence for any loss
of INSL3 during storage, or repeated freeze-thaw cycles, and
the TRFIA assay itself is very robust and reliable. The INSL3
concentration may be reflecting the dynamic nature of amniotic
fluid at this time in early pregnancy when its volume relationship
to fetal serum is changing dramatically, and its source is probably
also changing (Anand-Ivell and Ivell, 2014). Studies in the cow,
pig, and rat suggest that amniotic fluid samples in mid-late
gestation represent between 1-3rd and 1-10th of the INSL3
concentration in fetal serum at that time (Anand-Ivell et al.,
2011; Anand-Ivell and Ivell, 2014; Vernunft et al., 2016). Thus
while maximal INSL3 levels, as are evident between weeks 13
and 16, will depend on Leydig cell numbers and differentiation
status, the subsequent decline in INSL3 concentration may be
less due to a fall in production as to the changing fluid dynamics
of the amniotic compartment. It should also be noted that
amniotic fluid volume itself changes markedly across gestation
from approximately 10 ml at gestational weeks 8–9, to about
100 ml at week 12, increasing to nearly 400 ml by week 18 (Brace
and Wolf, 1989; Falcon et al., 2005; Rolo et al., 2010; Sandlin et al.,
2014). More importantly, the individual variation in amniotic
fluid volume at any one time point is also large (up to 10-fold
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between the 25th and 75th percentile; Sandlin et al., 2014). Thus
a change in amniotic hormone concentration can be as much
due to a specific change in hormone production as to a change
in amniotic fluid volume. It should be noted that significantly
reduced amniotic fluid volume (oligohydramnios) is associated
with utero-placental insufficiency and fetuses born SGA (Morris
et al., 2014). Unfortunately, no information regarding amniotic
fluid volume was available in the present retrospective study. In
a previous study (Anand-Ivell et al., 2008) ultrasound estimates
of amniotic fluid volume did not appear to vary in normal
pregnancies.
Comparing the cryptorchid and hypospadias cases with
controls, particularly within the physiologically informative
weeks 13–16, indicates firstly, a small mean increase of INSL3
concentration in both cryptorchid and hypospadias cases. This
had not been noted in the earlier analysis which made use of a
logistic regression analysis using tertiles from all gestational ages
(Jensen et al., 2015). Secondly, there appears to be a significantly
increased variance within these populations in cases compared to
controls, particularly noticeable in non-smokers. Thirdly, there is
an altered distribution, with the higher INSL3 values amongst the
cases occurring at an earlier gestational time-point. Interestingly,
looking at the later time-points in gestation (weeks 17–21)
suggests (though not significantly) that later in gestation INSL3
concentration becomes reduced in cases versus controls, thus
lending support to the recent studies indicating a reduced INSL3
concentration in the cord blood of infants with cryptorchidism
(Bay et al., 2007; Fenichel et al., 2015). Taken together, these
data imply an altered Leydig cell functionality in the cases
compared to controls, these cells possibly responding earlier
and more vigorously to the conditions which eventually lead to
the pathologies. There is no evidence for a reduced Leydig cell
function in these cases compared to controls. All subjects can be
considered as representative of the general population; this differs
therefore from the more extreme pharmacological situations in
humans or rodents, for example, where high diethylstilbestrol
or phthalate concentrations can lead to a high incidence of
cryptorchidism with accompanying INSL3 depletion (Emmen
et al., 2000; McKinnell et al., 2005; Palmer et al., 2009). A similar
significant increase in INSL3 expression was also noted in the
previous, smaller study of United States amniotic fluid samples
(Anand-Ivell et al., 2008) in relation to preeclampsia. Moreover,
a study of INSL3 in rats during puberty suggested that one
of the effects of maternal treatment with dibutyl phthalate or
diethylstilbestrol was to cause a precocious shift in the dynamics
of INSL3 expression, with the pubertal increase in hormone
expression being advanced upon maternal ED treatment (Ivell
et al., 2013). This appeared to be due to altered relative rates of
Leydig cell proliferation and differentiation.
There is no evidence for an influence of phthalate metabolites
or PFOS within the normal ranges of human exposure on the
incidence of cryptorchidism or hypospadias, even when analysis
is restricted to the sensitive window between weeks 13 and 16.
When looking at data from all available weeks of gestation,
both testosterone and progesterone also appear to be elevated
compared to controls in hypospadias samples both as mean, but
also in their variance (Levene’s test). Similarly, androstenedione
and progesterone are both slightly elevated in cryptorchid
cases. This effect is not apparent when assessing steroids only
within weeks 13–16 of pregnancy; here only testosterone is
significantly elevated, and then only in the hypospadias cases
compared to controls. This is an important finding, since it
would tend to refute the alternative explanation that any increases
in the concentration of amniotic hormones in cases compared
to controls might be due to a significantly reduced amniotic
fluid volume. These findings reinforce the notion that Leydig
cell function may indeed be physiologically different in cases
compared to controls, possibly over-responding to some external
‘stress’ factors. The increased variance is particularly interesting
since it implies that in this large population there are an
increased number of discrepant testes, some of which may
be under-producing, many of which may be over-producing,
compared to controls. Altogether the results indicate a larger
‘at risk’ population, more likely to be impacted by other
confounding factors, such as maternal smoking. The fact that
INSL3 and androstenedione (both Leydig cell biomarkers) are
closely correlated in the weeks 13–16 samples (cases and controls
combined) and that also androstenedione shows an increased
variance (Levene’s test), if not mean, in the hypospadias cases
reinforces this notion, that there is a larger ‘at risk’ population
amongst the cases compared to controls. None of the adrenal
steroids show similar patterns of significantly altered mean or
variance between cases and controls. The notion of increased
variance (as opposed to or in addition to increased mean) for
a parameter linked to pathology is not new. It is similar in
a way to the concept of “superfertility” that is reported to be
associated with at-risk pregnancies (Teklenburg et al., 2010) or
in the positive fertility effects of being a “quiet” embryo (Leese
et al., 2007).
Of possible extrinsic factors that might be involved in
altered Leydig cell function, maternal smoking and ED load
are likely to be relevant. It should be noted that of the ED
substances tested, both PFOS and the DEHP metabolite 5cx-
MEPP indicate a positive correlation with almost all steroids,
including the androgens, measuring all samples across gestation.
Interestingly, only the DiNP metabolite cx7-MMeHP, as well
as the DEHP metabolite 5cxMEPP showed significant negative
correlations, but only for INSL3 and androstenedione in this
sample population (Supplementary Tables S1–S5), whereas
PFOS and cotinine showed no specific interactions with INSL3.
In other words, only the specific Leydig cell biomarkers INSL3
and androstenedione were negatively impacted by putative
phthalate metabolites. Otherwise, these, like PFOS and cotinine,
had rather a positive impact on steroidogenesis, most of which
occurs in the fetal adrenal gland, suggesting an increased fetal
stress response due to the increased ED load. It is to be noted that
the results presented here have mostly used partial correlation
analysis corrected for gestational age, whereas an earlier analysis
of the same data, which showed a significant negative effect
of PFOS on INSL3 concentration, had corrected for additional
confounders and transformed the PFOS and hormone data
prior to logistic regression analysis using tertiles (Jensen et al.,
2015; Toft et al., 2016). Here, our analysis also indicated a
weak negative relationship between PFOS and INSL3 for weeks
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13–16 (Supplementary Table S5), though this failed to achieve
significance.
Cotinine, as an indicator of maternal smoking was generally
positively correlated with most steroids, when cases and controls
were combined across gestation. Similar findings have been
shown in the adult human, where smoking is linked to increased
circulating testosterone, though to decreased INSL3 (Atlantis
et al., 2009). In the present study there is no direct association of
any kind between cotinine levels and INSL3. However, cotinine,
being a relatively short-lived metabolite, is representative only
of acute rather than chronic smoking and hence is less likely to
correlate with differentiation-dependent parameters.
Finally, we assessed the possible impact of fetal growth on
the various biomarkers, using a calculated estimate of SGA.
Altogether, 7.2% of all pregnancies could be identified as SGA.
Amongst these SGA pregnancies, and as suggested by others
(Main et al., 2006), there appeared to be an increased risk
of hypospadias and cryptorchidism (together 9% of all cases
compared to 5% of control pregnancies), although none of the
measured biomarkers, including INSL3, showed any association
(negative or positive) with SGA. This thus appears to differ
from an earlier, smaller study of INSL3 in amniotic fluid, where
INSL3 values were shown to be significantly associated with
age-corrected birth weight (Anand-Ivell et al., 2008).
Taken together, the results from this first large case–control
study of amniotic fluid biomarkers, collected during the sensitive
gestational window for testicular organogenesis, shows that
particularly Leydig cell biomarkers appear to be increased, rather
than decreased as might have been expected, in cryptorchidism
and hypospadias. Significantly also, the variance about these
biomarkers is also increased, strongly suggesting that at a
population level Leydig cell functionality is more likely to
be impaired or at risk to other confounding factors in the
cases compared to controls. Moreover, when attempting to
identify possible factors with a negative impact on Leydig
cell functionality, the phthalate metabolites 5cx-MEPP or 7cx-
MMeHP indicated the requisite negative correlation with INSL3
and/or androstenedione, without, however, implicating these
compounds directly in the etiology of cryptorchidism or
hypospadias. This agrees with a recent quantitative study on
the impact of INSL3 and testosterone reduction on phenotype
in rats, wherein it is suggested that >40% reduction in either
hormone (or its mRNA) is required before there is evidence
of any phenotypic impact (Gray et al., 2015). Recently, several
studies have shown that INSL3 measured in cord blood, i.e.,
substantially later than its expression maximum in the fetus, is
significantly reduced in cryptorchid cases compared to controls
(Bay et al., 2007; Fenichel et al., 2015). Taken together, these
data support the notion that cryptorchidism and/or hypospadias
appear to be associated with a shift in the dynamics of INSL3
expression in the fetus, with precocious hormone expression
and presumably Leydig cell differentiation in cases compared
to controls. Thus INSL3, possibly as a result of exposure to
EDs, such as phthalates, would increase earlier and decline
sooner, and thus be out of synchrony with other ongoing
morphological processes, thereby encouraging cryptorchidism
and/or hypospadias.
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